Arcutis Biotherapeutics, Inc. ARQT Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s operating margin?
- Arcutis Biotherapeutics, Inc. (ARQT) reported operating margin of -12% in Q3 2025.
- How has Arcutis Biotherapeutics, Inc.'s operating margin changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s operating margin increased by 90.8% year-over-year, from -131.2% to -12%.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s operating margin?
- Over 2 years (2022 to 2024), Arcutis Biotherapeutics, Inc.'s operating margin has grown at a -91.1% compound annual growth rate (CAGR), from -8,183% to -65.3%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.